Brief: Adaptive Biotechnologies Q4 EPS USD -0.23
11/02/2025 21:05
Feb 11 (Reuters) - Adaptive Biotechnologies Q4 operating income USD -33.837 million vs. IBES estimate USD -37.8 million. * Q4 revenue USD 47.459 million vs. IBES estimate USD 46 million * Q4 operating expenses USD 81.296 million * Q4 net income USD -33.717 million vs. IBES estimate USD -38.9 million * Q4 adjusted EBITDA USD -16.4 million vs. IBES estimate USD -21.1 million
Recent news on Adaptive Biotechnologies
See all newsAdvisory: Alert incorrectly tagged to Adaptive Biotechnologies withdrawn
U.S. RESEARCH ROUNDUP-Cloudflare, Replimune, Walmart
U.S. RESEARCH ROUNDUP-Equinix, Meta, S&P Global
Adaptive Biotechnologies Corp reports results for the quarter ended June 30 - Earnings Summary
Adaptive Biotechnologies Q2 revenue rises 22%, beats estimates